Anti-Inflammatory Mesenchymal Stem Cells (MSC2) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy

Mesenchymal stem cells (MSCs) are very attractive candidates in cell-based strategies that target inflammatory diseases. Preclinical animal studies and many clinical trials have demonstrated that human MSCs can be safely administered and that they modify the inflammatory process in the targeted inju...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Waterman, Ruth S., Morgenweck, Jenny, Nossaman, Bobby D., Scandurro, Anna E., Scandurro, Sophia A., Betancourt, Aline M.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2012
Assuntos:
Enabling Technologies for Cell-Based Clinical Translation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659725/
https://ncbi.nlm.nih.gov/pubmed/23197860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2012-0025
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados